AKT1 and posterior cortical atrophy: The combined use of erufosine (ErPC3), an AKT inhibitor, and ABT‐737, a Bcl‐2 inhibitor, exhibits a synergistic effect in promoting autophagy‐induced apoptosis in PCa cells [66].